Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What are the long-term effects of statin therapy?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 128–129 (2006)Cite this article

boxed-textCholesterol Treatment Trialists' (CTT) Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomized trials of statins. Lancet 366: 1267–1278

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Edwards JE and Moore RA (2003) Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract 4: 18

    Article  Google Scholar 

  2. LaRosa JC et al. (1999) Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282: 2340–2346

    Article  CAS  Google Scholar 

  3. Cheung BM et al. (2004) Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 57: 640–651

    Article  CAS  Google Scholar 

  4. Kang S et al. (2004) Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 177: 433–442

    Article  CAS  Google Scholar 

  5. Amarenco P et al. (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35: 2902–2909

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, KY, USA

    Harold Bays

Authors
  1. Harold Bays
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harold Bays.

Ethics declarations

Competing interests

In over a decade of clinical research, H Bays has served as a Clinical Investigator for (and has received research grants from) pharmaceutical companies such as Abbott, Alteon, Arena, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Boehringer Mannheim, Bristol Myers Squibb, Eli Lilly, Esperion, Fujisawa, Ciba Geigy, GelTex, Glaxo, Genetech, Hoechst Roussel, KOS, Kowa, Lederle, Marion Merrell Dow, Merck, Merck Schering Plough, Miles, Novartis, Parke Davis, Pfizer, Pliva, Purdue, Reliant, Roche, Rorer, Regeneron, Sandoz, Sankyo, Sanofi, Searle, Shering Plough, SmithKline Beacham, Takeda, TAP, UpJohn, Upsher Smith, Warner Lambert, and Wyeth-Ayerst. He has also served as a consultant, speaker, and/or advisor to and for pharmaceutical companies such as AstraZeneca, Aventis, Bayer, Bristol Myers Squibb, KOS, Merck, Merck Schering Plough, Metabasis Therapeutics, Microbia, Novartis, Ortho-McNeil, Parke Davis, Pfizer, Roche, Sandoz, Sankyo, Sanofi Aventis, Shering Plough, SmithKline Beacham, Takeda, UpJohn, and Warner Lambert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bays, H. What are the long-term effects of statin therapy?. Nat Rev Cardiol 3, 128–129 (2006). https://doi.org/10.1038/ncpcardio0478

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0478

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing